Dr Reddys Laboratories (RDY) Other Non-Current Assets (2012 - 2026)

Dr Reddys Laboratories (RDY) recorded quarterly Other Non-Current Assets of $13.4 million in Q1 2026, up 9.12% quarter-over-quarter from $12.3 million in Q3 2025, and up 19.48% on a YoY basis from $11.2 million in Q1 2025.

Dr Reddys Laboratories (RDY) Other Non-Current Assets (2012 - 2026) Analysis & Trends

Dr Reddys Laboratories' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $13.4 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 19.48% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $13.4 million (up 19.48% YoY), while the FY2026 annual figure was $13.0 million, up 8.33% from the prior year.
  • Other Non-Current Assets was $13.4 million for Q1 2026 at Dr Reddys Laboratories, up from $12.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $64.4 million in Q3 2023 to a low of $9.7 million in Q1 2023.
  • Historically, Other Non-Current Assets has averaged $23.8 million across 5 years, with a median of $15.7 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 185.0% in 2023, then slumped 72.0% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $22.6 million in 2022, then surged by 185.0% to $64.4 million in 2023, then tumbled by 72.0% to $18.0 million in 2024, then slumped by 31.83% to $12.3 million in 2025, then rose by 9.12% to $13.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $13.4 million (Q1 2026), $12.3 million (Q3 2025), and $11.2 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn 13.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.41 Mn
Sep 30, 2025 12.29 Mn
Mar 31, 2025 11.22 Mn
Sep 30, 2024 18.03 Mn
Mar 31, 2024 19.65 Mn
Sep 30, 2023 64.38 Mn
Jun 30, 2023 54.92 Mn
Mar 31, 2023 9.73 Mn
Sep 30, 2022 22.59 Mn
Mar 31, 2022 11.89 Mn
Dec 31, 2021 31.00 Mn
Sep 30, 2021 38.95 Mn
Jun 30, 2021 35.14 Mn
Mar 31, 2021 11.44 Mn
Dec 31, 2020 51.87 Mn
Sep 30, 2020 48.11 Mn
Jun 30, 2020 47.86 Mn
Mar 31, 2020 11.65 Mn
Dec 31, 2019 43.04 Mn
Sep 30, 2019 12.73 Mn